Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (DFPH) Return on Sales (2021 - 2025)

Historic Return on Sales for Oncology Institute (DFPH) over the last 5 years, with Q3 2025 value amounting to 0.12%.

  • Oncology Institute's Return on Sales rose 400.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.16% for FY2024, which is 900.0% up from last year.
  • Oncology Institute's Return on Sales amounted to 0.12% in Q3 2025, which was up 400.0% from 0.14% recorded in Q2 2025.
  • Oncology Institute's Return on Sales' 5-year high stood at 0.35% during Q1 2022, with a 5-year trough of 0.39% in Q1 2023.
  • Over the past 5 years, Oncology Institute's median Return on Sales value was 0.15% (recorded in 2022), while the average stood at 0.12%.
  • Per our database at Business Quant, Oncology Institute's Return on Sales soared by 3700bps in 2022 and then tumbled by -7400bps in 2023.
  • Oncology Institute's Return on Sales (Quarter) stood at 0.19% in 2021, then increased by 21bps to 0.15% in 2022, then tumbled by -42bps to 0.22% in 2023, then surged by 40bps to 0.13% in 2024, then rose by 8bps to 0.12% in 2025.
  • Its last three reported values are 0.12% in Q3 2025, 0.14% for Q2 2025, and 0.19% during Q1 2025.